These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 6317623)
1. N-(functionalized alkyl) derivatives of 6-aminopenicillanic acid: a new series of specific inhibitors of beta-lactamase from Enterobacter cloacae P99. Calverley MJ; Begtrup M J Antibiot (Tokyo); 1983 Nov; 36(11):1507-15. PubMed ID: 6317623 [TBL] [Abstract][Full Text] [Related]
2. The beta-lactamase of Enterobacter cloacae P99. Chemical properties, N-terminal sequence and interaction with 6 beta-halogenopenicillanates. Joris B; De Meester F; Galleni M; Reckinger G; Coyette J; Frere JM; Van Beeumen J Biochem J; 1985 May; 228(1):241-8. PubMed ID: 2988516 [TBL] [Abstract][Full Text] [Related]
3. (6R,8S)-(2-benzimidazolyl)hydroxymethylpenicillanic acids as potent antibacterial agents and beta-lactamase inhibitors. Chen YL; Hedberg K; Guarino K; Retsema JA; Anderson M; Manousos M; Barrett J J Antibiot (Tokyo); 1991 Aug; 44(8):870-84. PubMed ID: 1655687 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 6-bromo-6-substituted penicillanic acid derivatives as beta-lactamase inhibitors. Bedini A; Balsamini C; Di Giacomo B; Tontini A; Citterio B; Giorgi L; Di Modugno E; Tarzia G Farmaco; 2002 Aug; 57(8):663-9. PubMed ID: 12361234 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of new C-6 alkyliden penicillin derivatives as beta-lactamase inhibitors. Di Giacomo B; Tarzia G; Bedini A; Gatti G; Bartoccini F; Balsamini C; Tontini A; Baffone W; Di Modugno E; Felici A Farmaco; 2002 Apr; 57(4):273-83. PubMed ID: 11989807 [TBL] [Abstract][Full Text] [Related]
6. Inactivation of beta-lactamases from Enterobacter cloacae by monophosphams. Bush K; Smith SA; Tanaka SK; Bonner DP J Antimicrob Chemother; 1988 Dec; 22(6):801-9. PubMed ID: 3266620 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and beta-lactamase inhibitory properties of 2 beta-(thio-substituted methyl)-penam 1,1-dioxides. Tanaka H; Tanaka M; Nakai A; Yamada S; Ishida N; Otani T; Torii S J Antibiot (Tokyo); 1988 Apr; 41(4):579-82. PubMed ID: 2836350 [No Abstract] [Full Text] [Related]
8. [A simple method of synthesis of S-sulfoxides of penicillanic acid and 6-alpha-bromo[chloro]-penicillanic acids]. Changov LS; Vasileva-Lukanova BK; Agapova NN; Tsenkova MM; Mondeshka DM; Ivanova ZT Antibiot Khimioter; 1990 Aug; 35(8):12-3. PubMed ID: 2176073 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and beta-lactamase inhibitory activities of some clavulanic acid analogues. Mak CP; Prasad K; Turnowsky F J Antibiot (Tokyo); 1983 Apr; 36(4):398-406. PubMed ID: 6602120 [TBL] [Abstract][Full Text] [Related]
10. Cefuroxime inhibition of cephalothin hydrolysis by the constitutive beta-lactamase from E. cloacae P99. Newman DJ; Mehta RJ; Bowie BA; Nash CH; Actor P J Antibiot (Tokyo); 1980 Oct; 33(10):1202-3. PubMed ID: 6969725 [No Abstract] [Full Text] [Related]
11. Inhibition of a class C beta-lactamase by a specific phosphonate monoester. Pratt RF Science; 1989 Nov; 246(4932):917-9. PubMed ID: 2814513 [TBL] [Abstract][Full Text] [Related]
12. The active site of the P99 beta-lactamase from Enterobacter cloacae. Joris B; Dusart J; Frere JM; van Beeumen J; Emanuel EL; Petursson S; Gagnon J; Waley SG Biochem J; 1984 Oct; 223(1):271-4. PubMed ID: 6333871 [TBL] [Abstract][Full Text] [Related]
14. (6R)-6-(substituted methyl)penicillanic acid sulfones: new potent beta-lactamase inhibitors. Adam S; Then R; Angehrn P J Antibiot (Tokyo); 1993 Apr; 46(4):641-6. PubMed ID: 8388871 [TBL] [Abstract][Full Text] [Related]
15. Chromophoric spin-labeled beta-lactam antibiotics for ENDOR structural characterization of reaction intermediates of class A and class C beta-lactamases. Mustafi D; Hofer JE; Huang W; Palzkill T; Makinen MW Spectrochim Acta A Mol Biomol Spectrosc; 2004 May; 60(6):1279-89. PubMed ID: 15134725 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and beta-lactamase inhibitory activity of new 6beta-cysteinesulfonamidopenicillanic acids. Changov LS; Naydenova ED; Ivanova GI; Gergova RT; Keuleyan EE; Aleksiev BV Bioorg Med Chem; 1999 Dec; 7(12):2899-904. PubMed ID: 10658594 [TBL] [Abstract][Full Text] [Related]
17. Kinetics and mechanism of beta-lactamase inhibition by phosphonamidates: the quest for a proton. Rahil J; Pratt RF Biochemistry; 1993 Oct; 32(40):10763-72. PubMed ID: 8399224 [TBL] [Abstract][Full Text] [Related]
18. beta-Lactamase inhibiting properties of 6-oxopenicillanic and 7-oxo-cephalosporanic acid derivatives. Ferri V; Pallavacini M; Valoti E; Villa L; Dall'Asta L; Pessa A Farmaco; 1991 Jan; 46(1 Suppl):191-207. PubMed ID: 1649611 [No Abstract] [Full Text] [Related]
19. Modification of 6-aminopenicillanic acid derivatives. Zukowski E; Eckstein Z Pol J Pharmacol Pharm; 1976; 28(4):379-87. PubMed ID: 185603 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and beta-lactamase inhibitory activity of 6-[(1-heteroarylthioethyl-1,2,3-triazol-4-yl)-methylene]penam sulfones. Im C; Maiti SN; Micetich RG; Daneshtalab M; Atchison K; Phillips OA; Kunugita C J Antibiot (Tokyo); 1994 Sep; 47(9):1030-40. PubMed ID: 7928691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]